Unknown PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT00774917

Numen Stent Assessment Using OCT Technique in a Single Center Study (NAUTIC)

Sponsor: CSC Pharmaceuticals

Interventions Numen

Updated 5 times since 2017 Last updated: Jun 22, 2009 Started: Oct 31, 2008 Primary completion: Sep 30, 2009 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00774917, this PHASE2/PHASE3 trial focuses on Hyperplasia and Restenosis and remains ongoing. Sponsored by CSC Pharmaceuticals, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CSC Pharmaceuticals
International Biomedical Systems S.p.A.

Data source: International Biomedical Systems S.p.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria
• Vienna (Austria), Austria